期刊文献+

精神分裂症与儿茶酚邻位甲基转移酶基因多态性的关联分析 被引量:5

Association between schizophrenia and catechol-O-methyltransferase gene polymorphism
原文传递
导出
摘要 目的 探讨精神分裂症与儿茶酚邻位甲基转移酶 (COMT)基因Val1 58Met多态性的关系。方法 采用聚合酶链反应技术检测符合诊断标准的 476例精神分裂症患者 (病例组 )和 2 0 7名正常对照者 (对照组 )的COMT基因Val 1 58Met多态性 ,并进行关联分析。结果  (1 )病例组与对照组基因型及等位基因分布频率的差异无显著性 (P >0 0 5) ;(2 )首次起病以阳性症状为主的患者Val 1 58Val基因型 (56 5 % )高于非阳性症状为主型者 (45 5 % ;P =0 0 7) ;(3)在男性患者中 ,不吸烟患者的Met1 58Met基因型分布频率 (1 1 9% )高于吸烟患者 (4 1 % ;P <0 0 5 ,OR =3 1 37) ;两者等位基因分布的差异无显著性 (P >0 0 5)。 Objective To investigate the association between Val158Met polymorphism in the Catechol O methyltransferase gene exon Ⅳ and schizophrenia in Chinese Han population Methods The case control association study was adopted to analyze the association between the Val158Met polymorphism in the Catechol O methyltransferase gene exon Ⅳ and schizophrenia in 476 DSM Ⅳ schizophrenics and 207 psychiatrically normal controls Results (1) In total, there were no significant differences of genotypic and allelic distribution between the schizophrenics and normal controls (2)Among the schizophrenics, the frequency of Val158Val genotype in patients with positive syndrome at the first onset was higher than that with non positive symptomatology (56 5% vs 45 5%, P =0 07) (3)The frequency of Met158Met genotype in non smokers of male patients was significantly higher than in smokers (11 9% vs 4 1%, P <0 05, OR =3 137) Conclusion The findings suggest that the COMT gene polymorphism may be associated with some clinical features of schizophrenia
出处 《中华精神科杂志》 CAS CSCD 北大核心 2002年第4期195-197,共3页 Chinese Journal of Psychiatry
关键词 精神分裂症 儿茶酚邻位甲基转移酶 多态现象 遗传学 COMT 聚合酶链反应技术 Schizophrenia Catechol O methyltransferase Polymorphism(Genetics) Case control studies
  • 相关文献

参考文献1

二级参考文献3

  • 1Chen C H,Am J Psychiatry,1999年,156卷,1273页
  • 2Li T,Psychiatr Genet,1996年,6卷,131页
  • 3Moises H W,Am J Med Genet,1995年,60卷,5期,465页

共引文献7

同被引文献72

  • 1潘明鸣,孙铁英.参与白三烯合成的酶基因多态性与支气管哮喘[J].中华结核和呼吸杂志,2004,27(9):621-623. 被引量:4
  • 2吴怀安,邓小敏,闫小华,刘铁榜,胡纪泽,沈其杰.儿茶酚氧位甲基转移酶基因多态性与精神分裂症关联分析[J].中国行为医学科学,2005,14(3):205-207. 被引量:19
  • 3曹海龙,许建明.消化系统疾病药物基因组学的临床研究进展[J].中国药理学通报,2006,22(9):1039-1042. 被引量:3
  • 4蒋晶晶,刘超.药物基因组学与口服降糖药[J].国际内分泌代谢杂志,2007,27(2):81-83. 被引量:1
  • 5Meltaer HY. An overview of themechanism of action of clozapine [J]. J Clin Psychiatry, 1994,55(supplB) :47
  • 6Marder SR, Winshingw C, Mintz J. Tow-year outcom of social skills training and group psychotherapy for outpatient with schizophrenia J [J]. Am J Psychiatry, 1996,153 : 585 - 592
  • 7Chakos M, Liebrman J, Hoffman E, et al. Effectiveness of second generation antipsyehotics in treatment-resistant schizophrenia: a re view and recta-analysis of randomized trials[ J ]. Am J Psychiatry 2002,158 : 518 - 526
  • 8Arranz MJ,Kerwin RW. Advances in the pharmacogenetic prediction of antipsychotic response[J]. Toxicology,2003,192:33- 35
  • 9Ickar D. Pharmacogenomics of psychiatric drug treatment[J ]. Psychiatr Clin North Am, 2003,26 : 303 - 321
  • 10Bailey DS,Bondal A,Furness LM. Phamacogenomics-it's not just phamacogentics. Curr ()pin Biotechnol, 1998,9 (6) : 595-601.

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部